ArticleDrug design, development and therapy2018

Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis.

Ying-Bin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.